HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Untch Selected Research

Circulating Neoplastic Cells

9/2017Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial.
5/2010Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Untch Research Topics

Disease

239Breast Neoplasms (Breast Cancer)
04/2024 - 07/2002
77Neoplasms (Cancer)
11/2023 - 01/2003
30Triple Negative Breast Neoplasms
04/2024 - 06/2014
30Pathologic Complete Response
11/2023 - 06/2009
7Neoplasm Metastasis (Metastasis)
10/2021 - 01/2010
6Disease Progression
01/2020 - 01/2003
6Infections
01/2020 - 06/2004
6Neutropenia
01/2020 - 06/2004
4Residual Neoplasm
09/2022 - 02/2009
4Brain Neoplasms (Brain Tumor)
06/2022 - 03/2018
4Febrile Neutropenia
01/2020 - 06/2004
4Exanthema (Rash)
01/2016 - 02/2012
4Cardiotoxicity
03/2013 - 06/2003
3Vomiting
01/2020 - 07/2002
3Nausea
01/2020 - 07/2002
3Carcinoma (Carcinomatosis)
10/2017 - 01/2003
3Diarrhea
07/2015 - 04/2010
3Thrombocytopenia (Thrombopenia)
06/2014 - 06/2009
3Anemia
07/2009 - 02/2008
2Fatigue
11/2023 - 01/2020
2Seroma
11/2023 - 07/2023
2Amenorrhea
01/2021 - 01/2019
2Breast Diseases (Breast Disease)
06/2020 - 01/2020
2Inflammatory Breast Neoplasms
11/2019 - 10/2014
2Circulating Neoplastic Cells
09/2017 - 05/2010
2Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 07/2014
2Heart Failure
03/2016 - 03/2010

Drug/Important Bio-Agent (IBA)

53Hormones (Hormone)IBA
03/2024 - 07/2002
52Trastuzumab (Herceptin)FDA Link
01/2023 - 06/2003
29human ERBB2 proteinIBA
03/2024 - 04/2010
29taxaneIBA
10/2021 - 08/2004
28Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 01/2003
25Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023 - 07/2002
24Epirubicin (Ellence)FDA LinkGeneric
01/2023 - 08/2004
24AnthracyclinesIBA
01/2021 - 02/2008
17Lapatinib (GW572016)FDA Link
01/2021 - 02/2006
15Biomarkers (Surrogate Marker)IBA
11/2023 - 10/2011
15ErbB Receptors (EGF Receptor)IBA
11/2023 - 03/2010
11Phenobarbital (Luminal)FDA Link
11/2023 - 10/2011
11Estrogen ReceptorsIBA
10/2021 - 07/2002
10Capecitabine (Xeloda)FDA Link
11/2023 - 10/2004
10Carboplatin (JM8)FDA LinkGeneric
10/2022 - 06/2014
10Bevacizumab (Avastin)FDA Link
01/2020 - 01/2010
9130-nm albumin-bound paclitaxelIBA
11/2023 - 04/2012
9Docetaxel (Taxotere)FDA Link
01/2020 - 04/2010
6pertuzumabIBA
06/2021 - 03/2013
5pembrolizumabIBA
03/2023 - 01/2020
5Immunoconjugates (Immunoconjugate)IBA
03/2023 - 01/2019
5Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 06/2003
5Immune Checkpoint InhibitorsIBA
06/2022 - 10/2016
5TamoxifenFDA LinkGeneric
01/2020 - 02/2007
5Monoclonal AntibodiesIBA
01/2017 - 10/2005
4Aromatase InhibitorsIBA
03/2024 - 02/2007
4Ado-Trastuzumab EmtansineIBA
09/2022 - 01/2019
4Epidermal Growth Factor (EGF)IBA
09/2022 - 02/2014
4Poly(ADP-ribose) Polymerase InhibitorsIBA
06/2022 - 01/2018
4liposomal doxorubicin (Doxil)FDA Link
01/2022 - 01/2017
4Messenger RNA (mRNA)IBA
01/2021 - 02/2013
3palbociclibIBA
11/2023 - 10/2021
3olaparibIBA
06/2023 - 01/2019
3sacituzumab govitecanIBA
03/2023 - 04/2021
3RNA (Ribonucleic Acid)IBA
01/2023 - 11/2021
3Tyrosine Kinase InhibitorsIBA
12/2021 - 01/2009
3PlatinumIBA
11/2021 - 01/2003
3MicroRNAs (MicroRNA)IBA
02/2020 - 08/2014
3Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 07/2002
3Cytotoxins (Cytolysins)IBA
01/2019 - 10/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2015 - 03/2004
3Taxoids (Taxanes)IBA
04/2012 - 01/2011
3epoetin betaIBA
11/2009 - 02/2008
2durvalumabIBA
04/2024 - 01/2021
2ribociclibIBA
03/2024 - 01/2023
2DenosumabFDA Link
11/2023 - 01/2022
2Ibandronic Acid (Boniva)FDA Link
11/2023 - 10/2013
2abemaciclibIBA
06/2023 - 03/2023
2N-acetyltalosaminuronic acid (NAT)IBA
01/2023 - 01/2014
2trastuzumab deruxtecanIBA
09/2022 - 06/2022
2AlpelisibIBA
06/2022 - 04/2021
2neratinibIBA
12/2021 - 06/2021
2veliparibIBA
11/2021 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 10/2017
2Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 01/2018
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 06/2004
2Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2016
2SolventsIBA
01/2019 - 03/2016
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2017 - 10/2014
2Indicators and Reagents (Reagents)IBA
04/2017 - 01/2017
2Formaldehyde (Formol)FDA Link
10/2016 - 10/2014
2ParaffinIBA
10/2016 - 10/2014

Therapy/Procedure

105Therapeutics
04/2024 - 01/2003
103Neoadjuvant Therapy
02/2024 - 04/2006
72Drug Therapy (Chemotherapy)
11/2023 - 07/2002
17Adjuvant Chemotherapy
01/2023 - 10/2005
7Radiotherapy
02/2024 - 07/2014
5Segmental Mastectomy (Lumpectomy)
02/2024 - 10/2014
5Mastectomy (Mammectomy)
07/2023 - 08/2015
4Precision Medicine
06/2020 - 03/2018
4Aftercare (After-Treatment)
11/2018 - 10/2011
3Operative Surgical Procedures
07/2023 - 02/2005
3Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 10/2004